HT941025N0104 - Sole Source JA.pdf
PDF 299 KB Posted
- Attached to
- Tissue Processor Maintenance
- Solicitation number
- HT941025N0104
- Issued by
-
Defense Health Agency
About this file
This document is a Justification and Approval (J&A) for a Sole Source Acquisition of Commercial Items for the Defense Health Agency (DHA). The contract is for Sakura Tissue Tek VIP Processor Maintenance to be performed by Sakura Finetek U.S.A., Inc. for the 673rd Medical Group at Joint Base Elmendorf-Richardson, Alaska. The contract has a base year from 1 July 2025 to 30 June 2026, with four additional one-year option periods through 30 June 2030, and an estimated total value of $110,000.00.
The procurement is being conducted as a sole source acquisition due to Sakura Finetek U.S.A., Inc. being the only vendor capable of providing the specific maintenance required for the Tissue-Tek Vacuum Infiltration Processor. Market research was conducted in May 2025, including a Notice of Intent to Sole Source posted on SAM.gov, which yielded no alternative vendors. The contract will be a firm-fixed-price purchase order using Operations and Maintenance (O&M) funding, with the DHA Healthcare Contracting Division - West (HCD-W) in San Diego, California managing the procurement.
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
FOR OFFICIAL USE ONLY - Source Selection Information – See FAR 2.101 and 3.104
DHA PGI 213.5, Attachment 1 (06-21-2018)
Justification and Approval (J&A) for Other than Full and Open Competition Sole Source Acquisition of Commercial Items
Conducted Pursuant to Federal Acquisition Regulation (FAR) Subpart 13.5
1. Identification of the agency and contracting activity:
This justification is executed by the Defense Health Agency Contracting Activity (DHACA), Healthcare Contracting Division - West (HCD-W), San Diego, CA, on behalf of the 673rd Medical Group, 5955 Zeamer Ave, Joint Base Elmendorf-Richardson, AK 99506-3702.
2. Nature and/or Description of Action being approved:
This is a fixed price Purchase Order service contract to provide Sakura Tissue Tek VIP Processor Maintenance from the current sole service provider, Sakura Finetek U.S.A., Inc.
3. Description of Supplies/Services:
The 673rd Medical Group, Joint Base Elmendorf-Richardson is requesting Sakura Tissue Tek VIP Processor Maintenance.
The objective of this sole source award is to establish a Purchase Order for a service contract for Sakura Tissue Tek VIP Processor Maintenance.
Period of Performance:
Base Year: 1 July 2025 – 30 June 2026 Option Year One: 1 July 2026 – 30 June 2027 Option Year Two: 1 July 2027 – 30 June 2028 Option Year Three: 1 July 2028 – 30 June 2029 Option Year Four: 1 July 2029 – 30 June 2030
Estimated value: $110,000.00
Type of Funding: Operations and Maintenance (O & M)
Contract Type: Firm-fixed-price
Location: 673rd Medical Group
5955 Zeamer Ave Joint Base Elmendorf-Richardson, AK 99506-3702
4. Statutory Authority Cited permitting other than full and open competition:
This acquisition of commercial items is conducted pursuant to FAR Subpart 13.5 in accordance with 41 U.S.C. 1901 Simplified Acquisition Procedures.
5. Rationale Justifying Use of the Statutory Authority Cited:
This sole source justification is prepared using the format at FAR 6.303-2, modified to reflect the procedures in FAR Subpart 13.5 in accordance with 41 U.S.C. 1901. Based on market research and previous acquisition history, it has been determined that the only vendor capable of meeting the Government’s requirements, Sakura Finetek U.S.A., Inc., is the only provider of the Sakura Tissue Tek VIP Processor Maintenance.
6. Efforts to Obtain Competition:
A Notice of Intent to Sole Source will be posted to SAM.gov to ensure there are no other capable vendors. Sakura Finetek U.S.A., Inc. is the only option due to nature of the maintenance required. If new vendors are found during this posting, the specialist will change acquisition strategy to competition.
7. Determination that Anticipated Cost to the Government will be Fair and Reasonable:
In accordance with the basis for award procedures at FAR 13.106-3, the Contracting Officer will utilize a comparison of the proposed price with prices found reasonable on previous purchases and a comparison of the price to the independent Government estimate provided by the requiring activity to determine the vendor's quoted price fair and reasonable. Additionally, the Government has historical pricing information from similar contracts that provided similar services. The cumulative data available to the Contracting Officer provides for the ability to determine a fair and reasonable price in accordance with FAR 13.106-3(a)(2)
8. Market Research:
Market research was conducted by technical experts in May 2025. This research consisted of reviews of similar previous procurements and reviewing mandatory sources. Search engines utilized include FPDS-NG, and GSA Advantage to identify potential sources that can meet the Government's requirements. The objective is to provide maintenance for Tissue-Tek Vacuum Infiltration Processor for the 673rd Medical Group, Joint Base Elmendorf-Richardson, AK. The maintenance for Tissue-Tek Vacuum Infiltration Processor can only be provided by Sakura Finetek U.S.A., Inc. Due to maintenance requirements, the Tissue-Tek parts and servicing technicians can only be provided by Sakura Finetek U.S.A., Inc., a large business. The Notice of Intent to Sole Source HT941025N0104 was posted on the SAM.gov website on 10 June 2025 in accordance with FAR Subpart 5.2. There were no responses to the Notice of Intent to Sole Source on SAM.gov. Market research has determined this requirement shall be sole sourced to a large business, Sakura Finetek U.S.A., Inc.
9. Other Facts:
Not applicable.
10. Interested Sources:
The only interested source was Sakura Finetek U.S.A., Inc., which is the only provider of the required maintenance. Market research and the posting of a Notice of Intent to Sole Source did not identify any additional interested parties.
11. Actions to overcome barriers:
The 673rd Medical Group and the DHA-CA, HCD-W will continue to survey and engage the market of any potential vendors that can provide the Sakura Tissue Tek VIP Processor Maintenance and will consider competing future requirements if there are other vendors capable of meeting the Government’s requirements.
COORDINATION & APPROVAL
12. Technical/Functional Representative: I certify that the information provided in this justification, is accurate and complete to the best of my knowledge and belief.
EDGARDO D. ORAPA, SSgt, USAF Date NCOIC, Contract Services
13. Requirements Certification: I certify that the information provided in this justification, is accurate and complete to the best of my knowledge and belief.
EDGARDO D. ORAPA, SSgt, USAF Date NCOIC, Contract Services
14. Contracting Officer Fair and Reasonable Cost Determination and Approval:
This procurement will utilize simplified acquisition procedures under FAR Subpart 13.5. are commercially available and have been previously procured, which establishes current and historical information that will be used as a basis for fair and reasonableness. Certified cost or pricing data will not be required in accordance with FAR 15.403-1(b)(3). I have determined that the anticipated cost to the Government for this contract action is fair and reasonable, and I certify that this justification is accurate and complete to the best of my knowledge and belief.
KAREN R. CUSSON Date Contracting Officer, DHACA, HCD-W, Alpha Branch
| Date1: 06/17/2025 | |
| Date2: 06/17/2025 | |
| Date3: 06/17/2025 | |
| 2025-06-17T07:53:29-0800 | |
| ORAPA.EDGARDO.DEGRAN.1379254710 |
| 2025-06-17T07:53:45-0800 | |
| ORAPA.EDGARDO.DEGRAN.1379254710 |
| 2025-06-17T09:49:40-0700 | |
| CUSSON.KAREN.R.1008590571 |
File details come from the government source that posted it. Updated .